Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06804109 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Non-invasive Vagus Nerve Stimulation (nVNS) and Cognition in Young Adult Vapers - A Pilot Study

Study acronym: nVNS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 60 to 100v5
  2. Primary endpoints: 2 to 3
    • Study description expanded, about 83 words
    v4
  3. Study sites: 3 to 1
    • Start date changed from estimate of Feb 28, 2025 to Mar 18, 2025
    v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 2 to 3
    • Start date: Feb 10, 2025 to Feb 28, 2025
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to assess the effects of non-invasive vagus nerve stimulation (nNVS) on cognitive functioning in the users of e-cigarettes or vaping products. The investigators will use a digital wellness companion product (TRUVAGA™ device) that provides mild transcutaneous nVNS. The participants will be randomized to receive either a 2-min nNVS stimulation or control stimulation in the neck region followed by completion of three cognitive tests of attention and executive function.
Trial Details
NCT Number NCT06804109
Lead Sponsor Temple University
Conditions
(from sponsor)		 Vaping
Related terms Vaping
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov